On November 9th, Senate Bill 2499, An Act relative to pharmaceutical access, costs, and transparency was polled out of the Senate Committee on Ways and Means (SWM). Senators will have until 5pm on November 13th to file amendments to the bill, and it will be debated before the full Senate next week. The bill is a redraft of S.2492, which was reported out of the Joint Committee on Health Care Financing on October 30th. The SWM redraft includes many of the same provisions and themes as S.2492, but differs in a few notable ways.